CD8A and neoplasm: NRTUAs preferentially invade immunosuppressive tumor-associated dendritic cells, reverse their immunosuppressive phenotype to an immune-activated phenotype, and rescue their ability to process and present tumor antigens to activate tumor antigen-specific CD8+ T cells [25].